1. Bora SK, Suri A, Khadgawat R, et al. Management of Cushing’s Disease: Changing Trend from Microscopic to Endoscopic Surgery. World Neurosurg. 2020;134:e46-e54. doi:10.1016/J.WNEU.2019.08.165
2. Møller MW, Andersen MS, Glintborg D, et al. Endoscopic vs. microscopic transsphenoidal pituitary surgery: a single centre study. Sci Rep. 2020;10(1). doi:10.1038/S41598-020-78823-Z
3. Broersen LHA, Biermasz NR, van Furth WR, et al. Endoscopic vs. microscopic transsphenoidal surgery for Cushing’s disease: a systematic review and meta-analysis. Pituitary. 2018;21(5):524-534. doi:10.1007/S11102-018-0893-3
4. Broersen LHA, van Haalen FM, Biermasz NR, et al. Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing’s disease: surgical outcome, mortality, and complications. Orphanet J Rare Dis. 2019;14(1). doi:10.1186/S13023-019-1038-0
5. Pablo A, Sofia B, Maximiliano T, et al. Endoscopic versus Microscopic Pituitary Adenoma Surgery: A Single-center Study. Neurol India. 2019;67(4):1015. doi:10.4103/0028-3886.266241
6. Qiao N. Outcome of endoscopic vs microsurgical transsphenoidal resection for Cushing’s disease. Endocr Connect. 2018;7(1):R26-R37. doi:10.1530/EC-17-0312
7. Kijima N, Kinoshita M, Takagaki M, Kishima H. Utility of a novel exoscope, ORBEYE, in gravity-assisted brain retraction surgery for midline lesions of the brain. Surg Neurol Int. 2021;12. doi:10.25259/SNI_320_2021
8. Muscas G, Battista F, Boschi A, Morone F, della Puppa A. A Single-Center Experience with the Olympus ORBEYE 4K-3D Exoscope for Microsurgery of Complex Cranial Cases: Technical Nuances and Learning Curve. J Neurol Surg A Cent Eur Neurosurg. 2021;82(5):484-489. doi:10.1055/S-0040-1719106
9. Göttsche J, Piffko A, Pantel TF, et al. Experiences with a 3D4K digital exoscope system (ORBEYE) in a wide range of neurosurgical procedures. J Neurol Surg A Cent Eur Neurosurg. Published online February 10, 2022. doi:10.1055/A-1768-4060
10. Vetrano IG, Acerbi F, Falco J, D’Ammando A, Devigili G, Nazzi V. High-Definition 4K 3D Exoscope (ORBEYETM) in Peripheral Nerve Sheath Tumor Surgery: A Preliminary, Explorative, Pilot Study. Oper Neurosurg (Hagerstown). 2020;19(4):480-488. doi:10.1093/ONS/OPAA090
11. Fiani B, Jarrah R, Griepp DW, Adukuzhiyil J. The Role of 3D Exoscope Systems in Neurosurgery: An Optical Innovation. Cureus. 2021;13(6). doi:10.7759/CUREUS.15878
12. Rotermund R, Regelsberger J, Osterhage K, Aberle J, Flitsch J. 4K 3-dimensional video microscope system (orbeye) for transsphenoidal pituitary surgery. Acta Neurochir (Wien). 2021;163(8):2097-2106. doi:10.1007/S00701-021-04762-X
13. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847-875. doi:10.1016/S2213-8587(21)00235-7
14. Lüdecke DK, Abe T. Transsphenoidal Microsurgery for Newly Diagnosed Acromegaly: A Personal View after More than 1,000 Operations. Neuroendocrinology. 2006;83(3-4):230-239. doi:10.1159/000095533
15. Rotermund R, Burkhardt T, Rohani Z, Jung R, Aberle J, Flitsch J. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly. Growth Horm IGF Res. 2018;41:64-70. doi:10.1016/J.GHIR.2018.03.002
16. Joshi SM, Cudlip S. Transsphenoidal surgery. Pituitary. 2008;11(4):353-360. doi:10.1007/S11102-008-0094-6
17. Alwani RA, de Herder WW, van Aken MO, et al. Biochemical predictors of outcome of pituitary surgery for Cushing’s disease. Neuroendocrinology. 2010;91(2):169-178. doi:10.1159/000258677
18. Masui K, Wajima D, Aketa S, Nishimura F. Efficacy of endoscopic transsphenoidal surgery for cushing’s disease: Case series and review of the literature. Neurol India. 2020;68(2):403-406. doi:10.4103/0028-3886.284363
19. Cebula H, Baussart B, Villa C, et al. Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing’s disease in 230 patients with positive and negative MRI. Acta Neurochir (Wien). 2017;159(7):1227-1236. doi:10.1007/S00701-017-3140-1